Cargando…

Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: An insight from molecular docking study

Multi-drug resistant in Mycobacterium tuberculosis (M.tb) is considered as major bottleneck in the treatment and cure of tuberculosis (TB). Several anti-tubercular drugs fail in its efficacy due to drug-resistant M.tb developed mechanism for resistance. So, research across globe has been carried out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Nisha, Jena, Pradip Kumar, Pradhan, Sukanta Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026281/ https://www.ncbi.nlm.nih.gov/pubmed/32090179 http://dx.doi.org/10.1016/j.heliyon.2019.e02693

Ejemplares similares

EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis
por: Amin, Anita G., et al.
Publicado: (2008)

Structure of the priming arabinosyltransferase AftA required for AG biosynthesis of Mycobacterium tuberculosis
por: Gong, Yicheng, et al.
Publicado: (2023)

Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis
por: Tan, Yong Zi, et al.
Publicado: (2020)

The C-Terminal Domain of the Arabinosyltransferase Mycobacterium tuberculosis EmbC Is a Lectin-Like Carbohydrate Binding Module
por: Alderwick, Luke J., et al.
Publicado: (2011)

Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus
por: Wang, Shuai, et al.
Publicado: (2022)

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Potential Anti-Mycobacterium tuberculosis Activity of Plant Secondary Metabolites: Insight with Molecular Docking Interactions
por: Kumar, Manu, et al.
Publicado: (2021)

Identification of a tomato UDP-arabinosyltransferase for airborne volatile reception
por: Sugimoto, Koichi, et al.
Publicado: (2023)

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis
por: Santhi, Natchimuthu, et al.
Publicado: (2011)

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
por: Cohen, Elisangela ML, et al.
Publicado: (2011)

Molecular modeling, simulation and docking of Rv1250 protein from Mycobacterium tuberculosis
por: Choudhary, Sumita, et al.
Publicado: (2023)

Dual-Target Mycobacterium tuberculosis Inhibition: Insights into the Molecular Mechanism of Antifolate Drugs
por: Ramharack, Pritika, et al.
Publicado: (2023)

Structural Models of Zebrafish (Danio rerio) NOD1 and NOD2 NACHT Domains Suggest Differential ATP Binding Orientations: Insights from Computational Modeling, Docking and Molecular Dynamics Simulations
por: Maharana, Jitendra, et al.
Publicado: (2015)

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Hydroxyproline O‐arabinosyltransferase mutants oppositely alter tip growth in Arabidopsis thaliana and Physcomitrella patens
por: MacAlister, Cora A., et al.
Publicado: (2015)

PLENTY, a hydroxyproline O-arabinosyltransferase, negatively regulates root nodule symbiosis in Lotus japonicus
por: Yoro, Emiko, et al.
Publicado: (2019)

Cryo-EM snapshots of mycobacterial arabinosyltransferase complex EmbB(2)-AcpM(2)
por: Zhang, Lu, et al.
Publicado: (2020)

Insights from the docking and molecular dynamics simulation of the Phosphopantetheinyl transferase (PptT) structural model from Mycobacterium tuberculosis
por: Rohini, Karunakaran, et al.
Publicado: (2013)

Identification of Missing Carbon Fixation Enzymes as Potential Drug Targets in Mycobacterium Tuberculosis
por: Katiyar, Amit, et al.
Publicado: (2018)

NOD1(CARD) Might Be Using Multiple Interfaces for RIP2-Mediated CARD-CARD Interaction: Insights from Molecular Dynamics Simulation
por: Maharana, Jitendra, et al.
Publicado: (2017)

Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis
por: Verma, Nitin Kumar, et al.
Publicado: (2013)

Screening and molecular dynamics simulation of compounds inhibiting MurB enzyme of drug-resistant Mycobacterium tuberculosis: An in-silico approach
por: Verma, Ankit, et al.
Publicado: (2023)

Exocyst mutants suppress pollen tube growth and cell wall structural defects of hydroxyproline O‐arabinosyltransferase mutants
por: Beuder, Steven, et al.
Publicado: (2020)

Drug Target Identification and Elucidation of Natural Inhibitors for Bordetella petrii: An In Silico Study
por: Rath, Surya Narayan, et al.
Publicado: (2016)

MTB-PCDB: Mycobacterium tuberculosis proteome comparison database
por: Jena, Lingaraja, et al.
Publicado: (2011)

Inhibition of Mycobacterium-RmlA by Molecular Modeling, Dynamics Simulation, and Docking
por: Harathi, N., et al.
Publicado: (2016)

Tuberculosis in Birds: Insights into the Mycobacterium avium Infections
por: Dhama, Kuldeep, et al.
Publicado: (2011)

Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an enzyme-catalyzed reaction
por: Kumar, Praveen, et al.
Publicado: (2005)

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study
por: Reza, Rahimasoom, et al.
Publicado: (2022)

Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis
por: Nguyen, Quang Huy, et al.
Publicado: (2018)

ATP-binding cassette (ABC) import systems of Mycobacterium tuberculosis: target for drug and vaccine development
por: Soni, Dharmendra Kumar, et al.
Publicado: (2020)

Molecular Epidemiology of Drug-Resistant Mycobacterium Tuberculosis in Japan
por: Mizukoshi, Fuminori, et al.
Publicado: (2021)

Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis
por: Anguru, Mohana Rao, et al.
Publicado: (2017)

Insights into transmission dynamics of Mycobacterium tuberculosis complex in Nepal
por: Shah, Yogendra, et al.
Publicado: (2022)

Insights from the molecular docking of curcumin to the virulent factors of Helicobacter pylori
por: Srivastava, Akhileshwar Kumar, et al.
Publicado: (2015)

MycoProtease-DB: Useful resource for Mycobacterium tuberculosis complex and nontuberculous mycobacterial proteases
por: Jena, Lingaraja, et al.
Publicado: (2012)

Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?
por: Ortega Ugalde, Sandra, et al.
Publicado: (2019)

Insilico analysis and molecular docking of resuscitation promoting factor B (RpfB) protein of Mycobacterium tuberculosis
por: Mylliemngap, Baphilinia Jones, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hdlvk7e62k544013g3ed9vmo1b